398 related articles for article (PubMed ID: 18433992)
1. Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
[TBL] [Abstract][Full Text] [Related]
2. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
[TBL] [Abstract][Full Text] [Related]
4. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
5. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
7. The growing diversity and spectrum of action of myeloid-derived suppressor cells.
Mantovani A
Eur J Immunol; 2010 Dec; 40(12):3317-20. PubMed ID: 21110315
[TBL] [Abstract][Full Text] [Related]
8. New insights into chronic inflammation-induced immunosuppression.
Kanterman J; Sade-Feldman M; Baniyash M
Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-induced immunosuppression and its neutralization.
Umansky V; Sevko A
Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
Ben-Baruch A
Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
12. Camouflage and sabotage: tumor escape from the immune system.
Poschke I; Mougiakakos D; Kiessling R
Cancer Immunol Immunother; 2011 Aug; 60(8):1161-71. PubMed ID: 21626032
[TBL] [Abstract][Full Text] [Related]
13. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
Allavena P; Sica A; Garlanda C; Mantovani A
Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
[TBL] [Abstract][Full Text] [Related]
14. Amino acid metabolism related to immune tolerance by MDSCs.
Yang B; Wang X; Ren X
Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019
[TBL] [Abstract][Full Text] [Related]
15. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cell heterogeneity and subset definition.
Peranzoni E; Zilio S; Marigo I; Dolcetti L; Zanovello P; Mandruzzato S; Bronte V
Curr Opin Immunol; 2010 Apr; 22(2):238-44. PubMed ID: 20171075
[TBL] [Abstract][Full Text] [Related]
17. On the armament and appearances of human myeloid-derived suppressor cells.
Poschke I; Kiessling R
Clin Immunol; 2012 Sep; 144(3):250-68. PubMed ID: 22858650
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
[TBL] [Abstract][Full Text] [Related]
19. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
Tadmor T; Attias D; Polliack A
Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
